Carisoprodol

On 2 registers61 medicines39 companies

Where it is registered

Each register with its number of medicines and a few of them.

Every register, a page at a time. Strengths and packs are on each medicine’s page.

9 results

Medicine	Register	Strength	Form	Status	Holder
Carisoprodol	United States	250MG, 350MG	tablet	Marketed	Natco
Carisoprodol CompoundCombination	United States	325MG; 200MG	tablet	Not marketed	Watson Labs
Carisoprodol and AspirinCombination	United States	325MG; 200MG	tablet	Not marketed	Genus
Carisoprodol, Aspirin and Codeine PhosphateCombination	United States	325MG; 200MG; 16MG	tablet	Not marketed	Ingenus Pharms NJ
Soma	United States	250MG, 350MG	tablet	Marketed	Mylan Speciality LP
Soma	United States	250MG	capsule	Not marketed	Mylan Speciality LP
Rela	United States	350MG	tablet	Not marketed	Schering
Soma CompoundCombination	United States	325MG; 200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	tablet	Not marketed	Meda Pharms
Soma Compound W/ CodeineCombination	United States	325MG; 200MG; 16MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	tablet	Not marketed	Meda Pharms

The same brand on several registers.

The companies holding its medicines, the most first.

Substances it shares a medicine with.

Compiled by Prognia from the public medicine registers of Anvisa and FDA. Each medicine’s page names its own source, licence and attribution.

Report an error or request removalCorrections from a register or a company are welcome.

For reference and learning, not treatment advice. Always check the official product information.

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.